Evidence map

ArticleThe lancet. Diabetes & endocrinology2018

Questioning the safety and benefits of evolocumab.

Luca Mascitelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29273162